Cue Biopharma, Inc. — insider transactions
5 transactions on record · CUE · CIK 1645460
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
—
Director share, 12m
20.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | 2026-07-30 | 4 | Ahlers James M | Chief Financial Officer | Grant or award | 51,000 | $0.00 | — | filing |
| 2026-08-03 | 2026-07-30 | 4 | Ahlers James M | Chief Financial Officer | Grant or award | 25,500 | $0.00 | — | filing |
| 2026-07-15 | 2026-07-13 | 2 | Borie Dominique Christian | Chief Medical Officer, Other | Grant or award | 31,500 | $0.00 | — | filing |
| 2026-07-15 | 2026-07-13 | 2 | Borie Dominique Christian | Chief Medical Officer, Other | Grant or award | 63,000 | $0.00 | — | filing |
| 2026-07-10 | 2026-07-09 | 1 | Camardo Daniel A. | Director | Grant or award | 21,800 | $0.00 | — | filing |